Syndax Pharmaceuticals, Inc. (SNDX)
8.575
-0.62
(-6.79%)
USD |
NASDAQ |
Nov 18, 16:00
8.57
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Price : 8.575 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 9.13 | 9.485 | 9.02 | 9.20 | 2.598M |
| Nov 16, 2026 | 9.34 | 9.475 | 9.06 | 9.13 | 2.466M |
| Nov 13, 2026 | 9.725 | 9.85 | 9.11 | 9.45 | 3.180M |
| Nov 12, 2026 | 9.47 | 9.93 | 9.30 | 9.54 | 2.830M |
| Nov 11, 2026 | 9.58 | 9.85 | 9.38 | 9.59 | 4.356M |
| Nov 10, 2026 | 9.61 | 9.87 | 9.29 | 9.49 | 2.943M |
| Nov 09, 2026 | 9.68 | 9.75 | 9.145 | 9.55 | 3.487M |
| Nov 06, 2026 | 9.59 | 9.78 | 9.22 | 9.54 | 4.171M |
| Nov 05, 2026 | 10.38 | 10.49 | 9.29 | 9.37 | 5.794M |
| Nov 04, 2026 | 14.55 | 14.69 | 9.99 | 10.45 | 15.06M |
| Nov 03, 2026 | 13.08 | 14.48 | 13.06 | 14.29 | 4.975M |
| Nov 02, 2026 | 13.62 | 13.77 | 12.90 | 13.10 | 3.177M |
| Oct 30, 2026 | 14.06 | 14.35 | 13.61 | 13.65 | 2.540M |
| Oct 29, 2026 | 14.36 | 14.66 | 13.98 | 14.15 | 4.882M |
| Oct 28, 2026 | 13.52 | 14.34 | 13.49 | 14.32 | 2.746M |
| Oct 27, 2026 | 13.25 | 13.88 | 13.05 | 13.69 | 2.705M |
| Oct 26, 2026 | 13.58 | 13.70 | 13.12 | 13.22 | 1.991M |
| Oct 23, 2026 | 13.60 | 13.61 | 13.20 | 13.40 | 4.250M |
| Oct 22, 2026 | 13.06 | 13.58 | 13.05 | 13.57 | 2.363M |
| Oct 21, 2026 | 13.32 | 13.59 | 13.10 | 13.15 | 2.588M |
| Oct 20, 2026 | 13.20 | 13.59 | 12.97 | 13.25 | 3.913M |
| Oct 19, 2026 | 12.95 | 13.18 | 12.80 | 13.09 | 2.193M |
| Oct 16, 2026 | 13.65 | 13.66 | 12.82 | 12.90 | 2.838M |
| Oct 15, 2026 | 13.58 | 14.05 | 13.43 | 13.65 | 2.626M |
| Oct 14, 2026 | 13.92 | 14.00 | 13.39 | 13.53 | 3.040M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.84 |
| Emergent BioSolutions, Inc. | 5.505 |
| Incyte Corp. | 117.82 |
| Vertex Pharmaceuticals, Inc. | 536.32 |
| Travere Therapeutics, Inc. | 50.23 |
Price Related Metrics
| PS Ratio | 2.623 |
| Earnings Yield | -27.61% |
| Market Cap | 771.66M |